cefadroxil anhydrous has been researched along with cefazolin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
| Babu, E; Endou, H; Narikawa, S; Takeda, M | 1 |
| Chairoungdua, A; Choi, BK; Endou, H; Jung, KY; Kim, DK; Kusuhara, H; Narikawa, S; Sekine, T; Shimoda, M; Sugiyama, Y; Takeda, M; Tojo, A | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| de Waart, DR; Duijst, S; Kunne, C; Oude Elferink, RP; Paulusma, CC; van de Wetering, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hiraoka, M; Kidono, M; Nakanomyo, H | 1 |
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Amery, K; Lemba, P; Levi, D | 1 |
| Ammann, R; Hardmeier, T; Neftel, K; Reinhardt, M | 1 |
| Brogard, JM; Comte, F | 1 |
| Anzai, N; Babu, E; Endou, H; Enomoto, A; Huang, XL; Khamdang, S; Narikawa, S; Noshiro, R; Onozato, ML; Piyachaturawat, P; Takeda, M; Tojo, A | 1 |
| Agrawal, A; Kaur, A; Mittal, M | 1 |
| Chen, D; Song, Z; Wang, Z | 1 |
| Jones, RN; Nguyen, HM | 1 |
| Ali, M; El-Sayed Ahmed, MM; Haddad, O; Pham, AN; Pham, SM; Sareyyupoglu, B; Thomas, M | 1 |
| Aliter, H; El Khateeb, O; Nasser, AS; Stewart, K | 1 |
2 review(s) available for cefadroxil anhydrous and cefazolin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
1 trial(s) available for cefadroxil anhydrous and cefazolin
| Article | Year |
|---|---|
[Treatment and surgery of abdominal septic states: comparison of two antibiotic therapies].
Topics: Abdomen; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefadroxil; Cefazolin; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Prospective Studies; Random Allocation | 1989 |
19 other study(ies) available for cefadroxil anhydrous and cefazolin
| Article | Year |
|---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Interaction of human organic anion transporters with various cephalosporin antibiotics.
Topics: Animals; Biological Transport; Cefadroxil; Cefotaxime; Ceftriaxone; Cell Line; Cephaloridine; Cephalosporins; Cephalothin; Estrone; Humans; Kinetics; Liver-Specific Organic Anion Transporter 1; Mice; Mice, Transgenic; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Tritium | 2002 |
Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.
Topics: Animals; Cephaloridine; Cephalosporins; Immunohistochemistry; Kidney; Mice; Organic Anion Transporters, Sodium-Independent; Rats | 2002 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Oral availability of cefadroxil depends on ABCC3 and ABCC4.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Biological Transport; Cefadroxil; Cell Membrane; Enterocytes; Estradiol; Intestinal Absorption; Intestinal Mucosa; Jejunum; Mice; Mice, Knockout; Multidrug Resistance-Associated Proteins | 2012 |
[Microbiological assay method of BMY-28100 and some other cephem antibiotic in serum and tissues. Development of new sample preparation with Evan's blue, a high albumin binding dye].
Topics: Animals; Biological Assay; Cefadroxil; Cefazolin; Cefprozil; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Evans Blue; Humans; Liver; Male; Rats; Rats, Inbred Strains; Serum Albumin | 1990 |
Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
Topics: Ampicillin; Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; beta-Lactamases; Cefaclor; Cefadroxil; Cefazolin; Cephalexin; Cephalosporins; Clostridium perfringens; Fusobacterium; Humans; Microbial Sensitivity Tests; Penicillin V | 1989 |
Cephalosporin-induced cholestatic jaundice.
Topics: Adult; Bacterial Infections; Cefadroxil; Cefazolin; Cephalexin; Cephalosporins; Cholestasis; Female; Humans | 1982 |
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Cefadroxil; Cefamandole; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cell Line; Cell Survival; Cephaloridine; Cephalosporins; Cephalothin; Dinoprost; Dose-Response Relationship, Drug; Humans; Kinetics; Mice; Mice, Transgenic; Organic Anion Transporters, Sodium-Independent; Probenecid; Rats; Transfection; Uricosuric Agents | 2003 |
Presumed pituitary abscess without infectious source treated successfully with antibiotics alone.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Brain Abscess; Cefadroxil; Cefazolin; Child; Chloramphenicol; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Pituitary Diseases; Tomography, X-Ray Computed | 2005 |
Study on the binding behavior of bovine serum albumin with cephalosporin analogues by chemiluminescence method.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefaclor; Cefadroxil; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Luminescence; Luminescent Measurements; Phthalic Acids; Serum Albumin, Bovine; Thermodynamics; Tryptophan | 2010 |
Reanalysis of cefazolin surrogate susceptibility breakpoints utilized as guidances for oral cephalosporin treatments of uncomplicated urinary tract infections: caution concerning application to cefadroxil.
Topics: Anti-Bacterial Agents; Cefadroxil; Cefazolin; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Practice Guidelines as Topic; Urinary Tract Infections | 2020 |
Absorbable antibiotic beads as an adjuvant therapy in treating ventricular assist devices driveline infection: A case report.
Topics: Adult; Anti-Bacterial Agents; Calcium Sulfate; Cardiomyopathies; Cefadroxil; Cefazolin; Chemotherapy, Adjuvant; Debridement; Dosage Forms; Drug Therapy, Combination; Heart-Assist Devices; Humans; Male; Prosthesis-Related Infections; Staphylococcus aureus; Tobramycin; Treatment Outcome; Vancomycin | 2020 |
Successful drainage of periaortic graft abscess and transcatheter aortic valve replacement in the same setting-A hybrid approach.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Stenosis; Cefadroxil; Cefazolin; Drainage; Heart Valve Prosthesis; Humans; Male; Methicillin; Probenecid; Rifampin; Transcatheter Aortic Valve Replacement | 2022 |